COMPOUND PROFILE / PEPTIDES & ANALOGUES
CJC-1295 DAC.
Research draftCJC-1295 DAC is a long-acting growth-hormone-releasing hormone analogue.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
CJC-1295 DAC is a long-acting growth-hormone-releasing hormone analogue.
Mechanism
Its drug-affinity complex prolongs exposure through albumin binding, stimulating pituitary growth-hormone release.
Human research
Small studies in healthy adults showed increased growth hormone and IGF-1. This does not establish recovery, muscle-building or longevity benefits.
Preclinical & other research
Animal studies investigated growth responses and hormonal signalling.
Safety & unknowns
Sustained hormonal stimulation and reported cardiovascular reactions warrant caution; long-term wellness-use safety is not established.
Regulatory status
Investigational; keep separate from products sold as CJC-1295 without DAC.
Reported use & evidence
The supplied CJC-1295 DAC profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.